[Antibiotic use and toxicity in liver diseases].

[Use of peg-intron in combined treatment of chronic liver disease caused by HIV infection]. Eksp Klin Gastroenterol (2003) 0.77

[Somatostatin and neurotensin in duodenal ulcer]. Ter Arkh (1982) 0.75

[Dynamics of the basal gastrin concentration of duodenal ulcer patients during the development of remission of the disease]. Ter Arkh (1985) 0.75

[Practical guidelines on how to treat patients with NSAID gastropathy from the point of view of the evidential medicine. Clinical examination]. Eksp Klin Gastroenterol (2006) 0.75

[Radioimmunologic and radioreceptor studies of the pharmacokinetics of the enkephalin analog dalargin in man]. Biull Eksp Biol Med (1986) 0.75

[The type of endocrine changes in patients with duodenal ulcer after single and long-term cimetidine administration]. Ter Arkh (1983) 0.75

[Project. Therapy of acid-dependent diseases. First Moscow Agreement, February 5, 2003]. Eksp Klin Gastroenterol (2003) 0.75

[VIII Congress of Russian Gastroenterological Scientific Society. XXXIV Session of the Central Research Institute of Gastroenterology (4-7 March, 2008, Moscow). Standards "Diagnosis and therapy of acid-dependent diseases including Helicobacter pylori-associated diseases" (Third Moscow Agreement, 04.02.05 with supplements adopted on 06.03.08 by VIII Congress of Russian Gastroenterological Scientific Society)]. Eksp Klin Gastroenterol (2008) 0.75

[Assessment of survival and risk of hepatocellular carcinoma in patients with cirrhosis of mixed (viral, alcoholic) etiology]. Ter Arkh (2002) 0.75

[Experience of application of Esomeprazole in patients with chronic hepatic diseases associated with acid-dependent diseases]. Eksp Klin Gastroenterol (2004) 0.75

[Alcoholic cholangitis as a variant of alcoholic disease of the liver (case report and review of the literature)]. Ter Arkh (2005) 0.75

[Thyrotropin response to thyroliberin administration in patients with duodenal ulcer and patients with depressive syndromes]. Ter Arkh (1983) 0.75

[Losek therapy of duodenal ulcer in contamination with different strains of Helicobacter pylori]. Klin Med (Mosk) (1999) 0.75

[Secretion of hypophyseal hormones in exacerbation of duodenal ulcer]. Ter Arkh (1979) 0.75

[Spontaneous thyroliberin-stimulated thyrotropin secretion in duodenal ulcer]. Ter Arkh (1980) 0.75

[Concentration of thyrotropin, thyroxine and triiodothyronine in the blood serum of patients with duodenal ulcer]. Ter Arkh (1979) 0.75

[The clinical importance of determining the endorphin level]. Ter Arkh (1992) 0.75

[Pharmacoeconomics in helicobacter pylori infection (lecture)]. Ter Arkh (2000) 0.75

[Development of a radioimmunologic method of determining gastrin-17 and outlook for its use in gastroenterology]. Lab Delo (1984) 0.75

[Depression as a side effect of alpha-interferon: mechanisms of development and criteria for experimental evaluation]. Eksp Klin Farmakol (2007) 0.75

[New prospects in treating chronic pancreatitis (clinico-pharmacoeconomic study)]. Eksp Klin Gastroenterol (2003) 0.75

[Blood endorphin levels in myocardial infarction]. Kardiologiia (1987) 0.75

[Some aspects of laboratory diagnosis of viral hepatitis B and C]. Ter Arkh (2003) 0.75

[Barrett esophagus: modern diagnosis, drug therapy and reduce risk of cancer]. Eksp Klin Gastroenterol (2009) 0.75

[Endocrine response to thyroliberin administration in duodenal ulcer]. Lab Delo (1984) 0.75

[Testosterone, progesterone and estradiol levels in duodenal ulcer in men]. Ter Arkh (1981) 0.75

[Myocarditis, polymyositis and Raynaud's syndrome in female patient with chronic hepatitis C]. Ter Arkh (1999) 0.75